SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001391609-18-000049
Filing Date
2018-03-16
Accepted
2018-03-16 16:48:51
Documents
62
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A-1 f10ka_nulf093017.htm 10-K/A 23178
  Complete submission text file 0001391609-18-000049.txt   2527941

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE nulf-20170930.xml EX-101.INS 516149
3 XBRL SCHEMA FILE nulf-20170930.xsd EX-101.SCH 36481
4 XBRL CALCULATION FILE nulf-20170930_cal.xml EX-101.CAL 33002
5 XBRL DEFINITION FILE nulf-20170930_def.xml EX-101.DEF 127078
6 XBRL LABEL FILE nulf-20170930_lab.xml EX-101.LAB 219918
7 XBRL PRESENTATION FILE nulf-20170930_pre.xml EX-101.PRE 207699
Mailing Address 2618 SAN MIGUEL SUITE 203 SAN CLEMENTE CA 92660
Business Address 2618 SAN MIGUEL SUITE 203 SAN CLEMENTE CA 92660 949-973-0684
NuLife Sciences, Inc. (Filer) CIK: 0001592603 (see all company filings)

IRS No.: 463876675 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-55805 | Film No.: 18696269
SIC: 2834 Pharmaceutical Preparations